Coexistence of primary AL amyloidosis and POEMS syndrome: efficacy of melphalan-dexamethasone and role of biochemical markers in monitoring the diseases course

Am J Hematol. 2010 Feb;85(2):131-2. doi: 10.1002/ajh.21581.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloidosis / blood*
  • Amyloidosis / drug therapy*
  • Antineoplastic Agents, Alkylating / administration & dosage*
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Biomarkers / blood*
  • Dexamethasone / administration & dosage*
  • Humans
  • Immunoglobulin Light Chains / blood*
  • Male
  • Melphalan / administration & dosage*
  • Middle Aged
  • Monitoring, Physiologic
  • POEMS Syndrome / blood*
  • POEMS Syndrome / drug therapy*
  • Vascular Endothelial Growth Factor A / blood

Substances

  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Hormonal
  • Biomarkers
  • Immunoglobulin Light Chains
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Dexamethasone
  • Melphalan